Cargando…
GENetic and clinical Predictors Of treatment response in Depression: the GenPod randomised trial protocol
BACKGROUND: The most effective pharmacological treatments for depression inhibit the transporters that reuptake serotonin (Selective Serotonin Reuptake Inhibitors – SSRIs) and noradrenaline (Noradrenaline Reuptake Inhibitors – NaRIs) into the presynaptic terminal. There is evidence to suggest that n...
Autores principales: | Thomas, Laura, Mulligan, Jean, Mason, Victoria, Tallon, Debbie, Wiles, Nicola, Cowen, Philip, Nutt, David, O'Donovan, Michael, Sharp, Deborah, Peters, Tim, Lewis, Glyn |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2426669/ https://www.ncbi.nlm.nih.gov/pubmed/18498636 http://dx.doi.org/10.1186/1745-6215-9-29 |
Ejemplares similares
-
Are multiple physical symptoms a poor prognostic factor or just a marker of depression severity? Secondary analysis of the GenPod trial
por: Green, Amy, et al.
Publicado: (2014) -
Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial
por: Gougoulaki, Marilia, et al.
Publicado: (2021) -
Allowing for non-adherence to treatment in a randomized controlled trial of
two antidepressants (citalopram versus reboxetine): an example from the
GENPOD trial
por: Wiles, N. J., et al.
Publicado: (2014) -
Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals
por: Crawford, Andrew A., et al.
Publicado: (2014) -
Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial
por: Tallon, Debbie, et al.
Publicado: (2016)